'Behavioral' label at Providence cost Jean Descamps his life

By Bram de Vries · Reporting from Amsterdam · August 6, 2026

When you are a man who has spent two decades watching the world’s cargo pass through Rotterdam—watching the sheer, brutal efficiency of global trade—you learn one thing: nothing…

The Cost of Thinking It's "Just Behavioral"

When you are a man who has spent two decades watching the world’s cargo pass through Rotterdam—watching the sheer, brutal efficiency of global trade—you learn one thing: nothing valuable happens by accident. Everything requires infrastructure, capital, and clear rules. What I read this week regarding Jean Descamps in Oregon is not a story about medical failure; it is a catastrophic illustration of regulatory overreach masquerading as compassion. It is the narrative of an entire sector—American healthcare—that has become so bogged down in bureaucratic caution that it forgets its primary function: to treat illness and facilitate life. The moment institutions decide they have the right to manage complex social problems, rather than simply providing defined services, the whole enterprise stalls.

The facts are stark, unvarnished, and profoundly embarrassing for a supposed pillar of Western civilization. Jean Descamps, 26 years old, was seen in bodycam footage at Providence Milwaukie Hospital in December 2023. He arrived in bad shape, suffering from street drug use, yet the staff’s judgment—repeatedly quoted by outlets like wshu.org and mirror.co.uk—was that he was "malingering." One hospital worker told police: "It's not really a medical problem, it's malingering." Another stated, "There is no medical reason for him to be here anymore, and it's all behavioural."

This institutional arrogance culminated in his discharge. He was released from the emergency room—after receiving naloxone—only to die shortly after from an overdose of drugs already in his system. The police officer on the scene captured a sentiment that rings with bitter clarity: "That guy does not need to be dead right now," and, regarding the hospital's mindset, "Oh, it's just another tweaker."

When Compassion Becomes Regulatory Paralysis

The ensuing debate is predictably academic. Experts like Dr. Judy Chertok rightly demand outrage every time someone dies from a preventable condition. They point to overwhelming statistics: addiction affects more than 40 million people in the U.S., and federal data released by SAMHSA showed that over 80% of those who need help receive no medical treatment whatsoever.

The solution, as Beth Meyerson explains, is not some grand cultural shift; it is a matter of supply-side economics applied to medicine. The "gold standards"—Methadone and buprenorphine—are proven tools. Congress lowered regulatory barriers for non-specialists to prescribe this medication in 2022 precisely because the market needed flexibility. Yet, what do we find? A system paralyzed by fear of litigation, a system that prefers vague ethical statements over clear, scalable protocols.

The hospital itself eventually issued a statement admitting they "fell short of our goal." But then, they immediately followed up with the classic deflection: "We do not have the capabilities nor the resources to manage the community needs once patients are discharged from our facilities." This is the ultimate capitalist dodge—the refusal to own the full cost of doing business. They provide the immediate service, collect the payment, and then declare that the subsequent social infrastructure necessary for survival is beyond their mandate.

The Failure to Treat as a Market Commodity

This entire episode transcends poor patient care; it speaks to a profound systemic failure rooted in regulatory capture. We are not discussing an isolated tragedy of neglect. We are observing the dangerous precedent set when medical institutions become more concerned with minimizing liability than maximizing human life. They treat addiction not as a chronic, manageable condition—a predictable drain on resources that requires robust state-backed infrastructure—but as a moral failure or a behavioral whim.

This pattern echoes one of history’s most damning betrayals: the Tuskegee Syphilis Study. In that era, medical professionals withheld known treatments from African American men simply because their utility was deemed observational for research purposes. The shared mechanism here is not surface resemblance; it is the systemic failure to provide necessary care or treatment based on the perceived utility of a population group—or in this case, the perceived difficulty of managing them post-discharge. When society's rules and institutions decide that certain lives are too complex, too expensive, or too difficult to manage outside their controlled environment, they effectively withhold life-saving resources.

The market principle is simple: if there is a need, there must be an efficient, scalable solution. The current regulatory framework in US addiction medicine has created a choke point—a bureaucratic bottleneck that prioritizes the protection of the institution over the survival of the patient. Until we dismantle the regulations that allow hospitals to claim they lack "resources" for community care, until we treat opioid use disorder with the same straightforward economic logic applied to diabetes or heart disease, this cycle of discharge and death will continue unabated.

'Behavioral' label at Providence cost Jean Descamps his life

The Cost of Thinking It's "Just Behavioral"

When Compassion Becomes Regulatory Paralysis

The Failure to Treat as a Market Commodity

Sources